Liver cancer treatment has changed a lot in five years, and how it changed tells you a lot about where it’s going. Most of ...

Adjuvant S-1 After Resection for BTC / ASCOT, Biliary tract cancer (BTC), cancer, cancer care, Cancer research, cancer ...

Cholestasis nutrition products market to grow from USD 107.6 Mn in 2026 to USD 223.8 Mn by 2036 at a 7.6% CAGR. Get segment, ...

The beat, and the unusual direction of the guidance.

Nice to meet you. I run the "Anticancer Drug Encyclopedia."I am a practicing pharmacist and hold certifications and ...

The Supreme Court has directed the Delhi government to list all hospitals failing to provide mandatory free treatment to economically weaker sections, while adding ILBS as a party to the ongoing legal ...

Supreme Court has asked Delhi govt to furnish details of all hospitals that have availed govt grants or benefits but failed to provide free treatment to a percentage of poor citizens as required in ...

The timing of cholecystectomy after abP should be based on disease severity and patient sex to optimize surgical outcomes.

Researchers report that Klebsiella pneumoniae enriched in the guts of primary biliary cholangitis patients can translocate to ...

Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral ...

Seladelpar produced broad, dose-dependent serum metabolomic changes consistent with enhanced fatty acid β-oxidation in PBC.

Summit Therapeutics said Monday that AstraZeneca has closed a $2 billion strategic equity investment in the company. AstraZeneca purchased 108,955 Summit preferred shares that can be ...